Source: ERJ Open Res, 4 (4) 00044-2018; 10.1183/23120541.00044-2018



Rating:

Share or cite this content

Citations should be made in the following way:
Alejandro A. Diaz, Diego J. Maselli, Farbod Rahaghi, Carolyn E. Come, Andrew Yen, Erick S. Maclean, Yuka Okajima, Carlos H. Martinez, Tsuneo Yamashiro, David A. Lynch, Wei Wang, Gregory L. Kinney, George R. Washko, Raúl San José Estépar. Pulmonary vascular pruning in smokers with bronchiectasis. ERJ Open Res, 4 (4) 00044-2018; 10.1183/23120541.00044-2018

Member's Comments

No comment yet.

Related content which might interest you: Pulmonary vascular pruning is associated with radiographic bronchiectasis progression Source: Virtual Congress 2021 – Exacerbations of chronic respiratory diseases, including SARS-CoV-2 Year: 2021 Pulmonary vascular remodelling in COPD versus bronchial asthma Source: Eur Respir J 2003; 22: Suppl. 45, 82s Year: 2003 Diffuse pulmonary fibrosis and pulmonary emphysema associated with paradoxically normal spirometry Source: Eur Respir J 2006; 28: Suppl. 50, 100s Year: 2006 Pulmonary vascular changes in COPD and idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2006 - Clinical physiology Year: 2006 Pulmonary vessels remodeling in COPD Source: International Congress 2016 – Pulmonary hypertension in lung disease Year: 2016 Characterization of pulmonary vascular remodelling in smokers and patients with mild COPD Source: Eur Respir J 2002; 19: 632-638 Year: 2002 Pulmonary hypertension in patients with idiopathic pulmonary fibrosis Source: Eur Respir Mon 2012; 57: 148-160 Year: 2012 Effect of pulmonary hemodynamics on the prognosis of patients with emphysematous COPD after LVRS Source: International Congress 2014 – Pulmonary hypertension in lung disease Year: 2014 Sildenafil inhibit dose-dependently profibrotic and remodelling effects of TGFbeta1 on pulmonary arteries from patients with idiopathic pulmonary fibrosis (IPF) Source: International Congress 2014 – Pulmonary hypertension in lung disease Year: 2014 Relation between pulmonary arterial remodeling and parenchymal disease in severe COPD and interstitial lung disease patients Source: International Congress 2014 – Pulmonary hypertension in lung disease Year: 2014 Pulmonary fibrosis in children Source: Eur Respir J 2004; 24: Suppl. 48, 618s Year: 2004 Pulmonary rehabilitation in smokers with COPD Source: Eur Respir J 2004; 24: Suppl. 48, 667s Year: 2004 Pulmonary hypertension and endothelial dysfunction in patients with bronchial asthma Source: Annual Congress 2008 - Pulmonary vascular disease and other pulmonary conditions: miscellaneous Year: 2008 CT measured pulmonary artery to aorta ratio as a predictor of pulmonary hypertension in COPD Source: International Congress 2014 – Pulmonary hypertension in lung disease Year: 2014 Sildenafil decreases the contractile response to serotonin (5HT) in pulmonary arteries from patients with idiopathic pulmonary fibrosis (IPF) and pulmonary hypertension (PH) Source: International Congress 2014 – Pulmonary hypertension in lung disease Year: 2014 Pulmonary tuberculosis in smokers Source: International Congress 2019 – Tuberculosis: a public health approach Year: 2019 Pulmonary arterial hypertension in combined pulmonary emphysema and fibrosis Source: Annual Congress 2005 - Pulmonary arterial hypertension diagnosis and therapy Year: 2005 Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome Source: Eur Respir J 2010; 35: 105-111 Year: 2010 Pulmonary hypertension in idiopathic pulmonary fibrosis Source: Annual Congress 2010 - Clinical aspects in pulmonary fibrosis Year: 2010